Boxer Capital as of Sept. 30, 2017
Portfolio Holdings for Boxer Capital
Boxer Capital holds 30 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Avexis | 17.6 | $77M | 800k | 96.73 | |
| Beigene (BGNE) | 14.1 | $62M | 600k | 103.46 | |
| Clovis Oncology | 9.4 | $41M | 500k | 82.40 | |
| Macrogenics (MGNX) | 9.3 | $41M | 2.2M | 18.48 | |
| Medicines Company | 7.6 | $33M | 900k | 37.04 | |
| Esperion Therapeutics (ESPR) | 5.7 | $25M | 500k | 50.12 | |
| Ptc Therapeutics I (PTCT) | 5.7 | $25M | 1.3M | 20.01 | |
| Blueprint Medicines (BPMC) | 4.0 | $17M | 250k | 69.67 | |
| G1 Therapeutics (GTHX) | 3.6 | $16M | 629k | 24.89 | |
| Kura Oncology (KURA) | 2.9 | $13M | 845k | 14.95 | |
| Mirati Therapeutics | 2.8 | $12M | 1.0M | 11.70 | |
| Puma Biotechnology (PBYI) | 2.7 | $12M | 100k | 119.75 | |
| La Jolla Pharmaceuticl Com Par | 2.1 | $9.3M | 268k | 34.78 | |
| Cymabay Therapeutics | 1.9 | $8.2M | 1.0M | 8.06 | |
| Zogenix | 1.6 | $7.0M | 200k | 35.05 | |
| Reata Pharmaceuticals Inc Cl A | 1.4 | $6.2M | 200k | 31.10 | |
| Strongbridge Bioph shs usd | 1.4 | $5.9M | 857k | 6.90 | |
| Gtx Inc Del | 1.1 | $4.8M | 565k | 8.44 | |
| Aquinox Pharmaceuticals | 1.0 | $4.4M | 313k | 14.19 | |
| Axovant Sciences | 0.8 | $3.4M | 500k | 6.88 | |
| Regulus Therapeutics | 0.6 | $2.7M | 2.2M | 1.25 | |
| Bellerophon Therapeutics | 0.6 | $2.6M | 1.9M | 1.42 | |
| Aradigm | 0.5 | $2.1M | 500k | 4.20 | |
| Sunesis Pharmaceuticals Inc Ne | 0.5 | $2.0M | 1.0M | 1.94 | |
| Barclays Bk Plc Ipath S&p500 Vix etf | 0.5 | $2.0M | 50k | 39.20 | |
| Eiger Biopharmaceuticals | 0.3 | $1.5M | 138k | 11.00 | |
| Syndax Pharmaceuticals (SNDX) | 0.3 | $1.2M | 100k | 11.70 | |
| Nabriva Therapeutics | 0.2 | $710k | 87k | 8.19 | |
| Onconova Therapeutics Inc *w exp 07/07/202 | 0.1 | $528k | 309k | 1.71 | |
| Onconova Therapeutics | 0.0 | $92k | 242k | 0.38 |
